+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience



Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience



Heart Rhythm 9(12): 1954-1961



A medical device advisory issued by St Jude Medical in November 2011 estimated 0.63% all-cause abrasion rate on their Riata and Riata ST silicone high-voltage lead families (Riata/ST), leading to Food and Drug Administration class I recall. We performed an independent comparative, long-term electrical survival analysis of Riata/ST and 3 other high-voltage lead families in a large national cohort of patients. To evaluate long-term electrical survival of Riata/ST leads relative to other commonly evaluated high-voltage leads. Failure rates of Riata/ST, Sprint Quattro Secure (Quattro), Sprint Fidelis (Fidelis), and Endotak Reliance G/SG (Endotak) leads from the Veterans Administration's National Cardiac Device Surveillance Center database, consisting of 24,145 patients with remote transmissions since 2003, were analyzed. Survival Probabilities were determined with Kaplan-Meier survival analysis and compared using the log-rank test. Of 1,403 Riata/ST, 6,091 Quattro, 5,073 Fidelis, and 2,401 Endotak leads identified, 5-year survival probability of Riata/ST leads (97.5%) was significantly lower than that of Quattro (99.3%) and Endotak (99.4%) leads (P <.0001) but higher than that of Fidelis leads (89.6%) (P <.0001). Riata ST leads showed a 5-year survival of 95.5% (95% confidence interval 92.4-97.4) compared to 98.4% (95% confidence interval 97.1-99.1) in Riata leads (P = .003). There is decreased survival probability of Riata/ST leads compared to other contemporary high-voltage leads, with decreased survival of Riata ST silicone compared to Riata lead series. Careful long-term follow-up should be maintained in patients with Riata/ST leads in order to prevent inappropriate shocks or failed device interventions. Our results were determined in advance of Food and Drug Administration class I recall, which suggested that large-scale remote monitoring may be an effective tool for continued implantable cardioverter-defibrillator system surveillance.

(PDF emailed within 0-6 h: $19.90)

Accession: 054164553

Download citation: RISBibTeXText

PMID: 22871583

DOI: 10.1016/j.hrthm.2012.08.006


Related references

Long-term Electrical Survival Analysis of Riata and Riata ST Silicone Leads—National VA Experience. 2012

Prevalence of externalized conductors in Riata and Riata ST silicone leads: results from the prospective, multicenter Riata Lead Evaluation Study. Heart Rhythm 10(12): 1778-1782, 2014

Riata and Riata ST defibrillator leads failure: cable externalization is one problem, but other electrical failures seem more preoccupant. European Heart Journal 34(Suppl 1): P1396-P1396, 2013

National Consultant in Cardiology Experts' Group Guidelines on dealing with patients implanted with some St. Jude Medical Riata and Riata ST leads. Kardiologia Polska 72(6): 576-582, 2016

Independent multicenter study of Riata and Riata ST implantable cardioverter-defibrillator leads. Heart Rhythm 10(3): 361-365, 2013

Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads. Heart Rhythm 9(8): 1227-1235, 2013

Contribution of ethylenetetrafluoroethylene (ETFE) insulation to the electrical performance of Riata® silicone leads having externalized conductors. Journal of Interventional Cardiac Electrophysiology 37(2): 141-145, 2014

Independent Multicenter Study of Riata and Riata ST ICD Leads. Heart Rhythm 9(9): 1577-1578, 2012

Prevalence of asymptomatic and electrically undetectable intracardiac inside-out abrasion in silicon-coated Riata® and Riata® ST implantable cardioverter-defibrillator leads. International Journal of Cardiology 167(1): 254-257, 2014

Multicenter experience with extraction of the Riata/Riata ST ICD lead. Heart Rhythm 11(9): 1613-1618, 2015

Optimal management of Riata leads with no known electrical abnormalities or externalization: a decision analysis. Journal of Cardiovascular Electrophysiology 26(2): 184-191, 2015

Cable externalization and electrical failure of the Riata family of implantable cardioverter-defibrillator leads: A systematic review and meta-analysis. Heart Rhythm 12(6): 1233-1240, 2016

Falha de integridade dos eltrodos de desfibrilhao Riata e Riata ST: um problema atual. Revista Portuguesa de Cardiologia 32(10): 823-826, 2013

Mechanisms, predictors, and trends of electrical failure of Riata leads. Heart Rhythm 10(10): 1453-1459, 2014

Failure-free survival of the Riata implantable cardioverter-defibrillator lead after a very long-term follow-up. Indian Pacing and Electrophysiology Journal 2019, 2019